The invention relates to novel arylalkenylpropargylamine derivatives of general formula (I) or enantiomers or diastereomers thereof or salts, optionally pharmaceutically acceptable salts, or solvates of any of these. The compounds can be used in treating or preventing a disease or condition in a mammal related to monoamine oxidase dysfunction, especially in neurodegenerative diseases, e.g. Parkinson's disease, Alzheimer's disease or Huntington's disease.
本发明涉及一类新型的芳基
烯丙
炔丙胺衍
生物,其具有通用公式(I)或其对应的手性异构体或对映异构体或盐,可选用药物上可接受的盐,或者这些化合物的溶剂化物。这些化合物可用于治疗或预防哺乳动物与单胺
氧化酶功能障碍相关的疾病或状况,特别是在神经退行性疾病中,例如帕
金森病、阿尔茨海默病或亨廷顿病。